Impact of age on implementation and tolerability of guideline-directed medical therapy in heart failure with reduced ejection fraction
Elderly patients constitute a growing proportion of patients with heart failure with reduced ejection fraction (HFrEF), yet remain underrepresented in randomized clinical trials shaping treatment recommendations. We evaluated age-related differences in real-world contemporary HFrEF care. TITRATE-HF is a pr...